# Neuromyelitis Optica (NMO) & Cetirizine

> **NCT02865018** · PHASE1,PHASE2 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 16 (actual)

## Conditions studied

- Neuromyelitis Optica

## Interventions

- **DRUG:** cetirizine

## Key facts

- **NCT ID:** NCT02865018
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02865018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02865018, "Neuromyelitis Optica (NMO) & Cetirizine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02865018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*